VANCOUVER, Sept. 15 /PRNewswire-FirstCall/ - AnorMED Inc. (“AnorMED” or the “Company”) (NASDAQ:ANOR - News; TSX:AOM - News) today announced that, in accordance with its established policy, the Toronto Stock Exchange (“TSX”) has deferred its review of AnorMED’s shareholder rights plan. The TSX policy states that, in the context of an active take-over bid, TSX will normally defer its own review until the appropriate securities commission has determined whether or not it will intervene pursuant to National Policy 62-202 of the Canadian Securities Administrators. The TSX’s stated practice is that if the securities commission does not intervene, the TSX will generally not object to the adoption of the Plan, provided that it is ratified by security holders at a meeting held within six months following the date of adoption of the Plan.
